Heba Elmotasem
- Pharmaceutical Science top 2%
- Biomaterials top 10%
- Food Science top 10%
- Materials Chemistry
- Molecular Biology
- Co-authors
- Abeer SalamaGhada E. A. AwadAmina L. MohamedDina MostafaMarwa Hasanein AsfourHussein O. AmmarSalama HaHala K. Farag
- Topics
- Advancements in Transdermal Drug Delivery (7 papers)Advanced Drug Delivery Systems (4 papers)Nanoplatforms for cancer theranostics (3 papers)
In The Last Decade
Heba Elmotasem
16 papers receiving 560 citations
Peers
Comparison fields: 5 of 94
- Pharmaceutical Science 195
- Biomaterials 135
- Food Science 118
- Materials Chemistry 113
- Molecular Biology 79
Countries citing papers authored by Heba Elmotasem
This map shows the geographic impact of Heba Elmotasem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heba Elmotasem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heba Elmotasem more than expected).
Fields of papers citing papers by Heba Elmotasem
This network shows the impact of papers produced by Heba Elmotasem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heba Elmotasem. The network helps show where Heba Elmotasem may publish in the future.
Co-authorship network of co-authors of Heba Elmotasem
This figure shows the co-authorship network connecting the top 25 collaborators of Heba Elmotasem. A scholar is included among the top collaborators of Heba Elmotasem based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heba Elmotasem. Heba Elmotasem is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 5 | |
| 4 | 3 | |
| 5 | 19 | |
| 6 | 27 | |
| 7 | 13 | |
| 8 | 34 | |
| 9 | 21 | |
| 10 | 25 | |
| 11 | 36 | |
| 12 | 90 | |
| 13 | 73 | |
| 14 | 42 | |
| 15 | 120 | |
| 16 | 40 | |
| 17 | 20 |
About Heba Elmotasem
Heba Elmotasem is a scholar working on Pharmaceutical Science, Biotechnology and Molecular Medicine, having authored 17 papers that have together received 569 indexed citations. Recurring topics across this work include Advancements in Transdermal Drug Delivery (7 papers), Advanced Drug Delivery Systems (4 papers) and Nanoplatforms for cancer theranostics (3 papers). The work is most often cited by research in Pharmaceutical Science (195 citations), Molecular Medicine (52 citations) and Biomaterials (135 citations). Heba Elmotasem has collaborated with scholars based in Egypt, Japan and Indonesia. Frequent co-authors include Abeer Salama, Ghada E. A. Awad, Amina L. Mohamed, Dina Mostafa, Marwa Hasanein Asfour, Hussein O. Ammar, Salama Ha, Hala K. Farag, Mona M. Agwa and Alaa H. Salama. Their work appears in journals such as International Journal of Pharmaceutics, RSC Advances and International Journal of Biological Macromolecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.